# Abridge Closes $316M Series E Extension at $5.3B Valuation to Scale Ambient AI Clinical Documentation

> financing · REPORTED · 2026-04-30

Abridge closed a reported $316 million Series E extension in April 2026, adding to its prior $300 million Series E led by a16z, bringing total funding to over $750 million at a $5.3 billion valuation. The company, deployed across more than 150 health systems including Kaiser Permanente and Mayo Clinic, is now expanding its ambient AI documentation platform into revenue cycle management.

About Abridge: Abridge is a Pittsburgh-based generative AI company that converts real-time doctor-patient conversations into structured clinical notes integrated directly into Epic EHR, serving over 150 health systems and targeting the clinical documentation and revenue cycle markets.

- Company: Abridge
- Sector: digital health
- Primary source: https://techjacksolutions.com/ai-brief/abridge-closes-reported-316m-series-e-extension-at-53b-valua/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.